.jpg)
Dutch-based leading European stem cell storage bank, Cryo-Save Group N.V. (NYSE Euronext: CRYO) completed its listing on NYSE Euronext’s Amsterdam market today.
Cryo-Save has storage and processing facilities in 5 countries and is operating in 38 countries in Europe, Asia and Africa. With over 115.000 samples stored, Cryo-Save is Europe’s largest adult stem cell storage bank. The company sets the highest quality standards in stem cell storage, as it aims to make an important contribution to conquer possible life-threatening diseases for children and adults in the future. The company is committed to further improve stem cell cryo-preservation techniques, by participating in European Commission funded projects, in Universities and Hospitals.
Cryo-Save shares trade on NYSE Euronext under the symbol “CRYO” and are denominated in Euros. After opening, the first market price was € 6.30 per share. Based on the total number of 9,639,191 shares the total market capitalization of the company at opening price was € 60,726,903
Marc Waeterschoot, Chief Executive, commented: “Being a Dutch company, with most of our business on the continent, a listing on NYSE Euronext’s European market should increase our visibility as well as liquidity and will therefore add value to the company and to the shareholders that have invested in us since our listing on AIM in London in 2007.
“We welcome Cryo-Save to NYSE Euronext’s European market, the largest and most liquid market in Europe. As a leading stem cell storage bank in Europe the company will gain unmatched access to investors in the eurozone.”, said Joost van der Does de Willebois, CEO of Euronext Amsterdam.
